PharmTech News

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Articles

A landmark study by the National Institutes of Health determines that Lucentis is highly effective as a treatment for diabetic retinopathy.

Lucentis Effective for the Treatment of Proliferative Diabetic Retinopathy

High-dose axalimogene filolisbac immunotherapy will advance to expansion phase.

Advaxis Presents New Data at the Society for Immunotherapy of Cancer 2015 Annual Meeting

The University of Pittsburgh Partners with Biopharmaceutical Company

Roche will invest in Switzerland but leave sites in Ireland, Spain, Italy, and the US as it focuses on lower-volume, specialized medicines.

Roche Downsizes Small-Molecule Manufacturing and Exits Four Sites

TrakCel Ltd. Adds Cognate BioSevices to Connected Services Program

AstraZeneca’s solid-dose facility in Taizhou, China received ISPE’s FOYA 2015 Overall Winner award.

AstraZeneca China Wins ISPE Facility of the Year Award

AstraZeneca will add ZS Pharma’s leading ion-channel candidate to its pipeline.

AstraZeneca Acquires ZS Pharma

South Africa’s Biovac Institute, which develops and produces vaccines for the country, launched a public-private partnership with Pfizer to enable local manufacturing of Prevenar 13, a vaccine against pneumonia-causing bacteria.

Pfizer Transfers Vaccine Technology for Production in South Africa

At least 70 patents for Humira will protect the legacy product from biosimilar competitors, according to information presented during the company’s third-quarter earnings call.

AbbVie CEO: Humira Biosimilars Won’t Reach Market Until at Least 2022

The company is voluntarily recalling the epinephrine injection, USP because of potential inaccurate dosage delivery.

Bio/Pharma News